about
RAD52 variants predict platinum resistance and prognosis of cervical cancer.CASP7 variants modify susceptibility to cervical cancer in Chinese women.REV3L, a promising target in regulating the chemosensitivity of cervical cancer cells.Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy.TNF rs1799964 as a Predictive Factor of Acute Toxicities in Chinese Rectal Cancer Patients Treated With Chemoradiotherapy.Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes.Multiple Cycles of Neoadjuvant Chemotherapy Associated With Poor Survival in Bulky Stage IIIC and IV Ovarian Cancer.Risk factors for human papillomavirus infection in Shanghai suburbs: a population-based study with 10,000 women.Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer.The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation (APOLLO) symposium in Shanghai.XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis.Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.DNA polymerase ζ as a potential biomarker of chemoradiation resistance and poor prognosis for cervical cancer.Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open QuestionsAsian Society of Gynecologic Oncology International Workshop 2018A phase II, randomized study of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study
P50
Q34500320-71285052-34AB-4DA7-B134-25B55156EC90Q35188981-4FE2FBC3-0C9F-4172-872E-21F9843B34D1Q35190445-4CF5DA03-DAF2-48E1-A28B-6272DF35B66DQ36015146-C358D1B8-1B72-4A77-804B-5EF41708A2FDQ37016664-6AD3E878-CDCA-4EFC-89D3-823A783850B7Q39214172-35380295-E2A4-45F0-91DE-C78E51ED2958Q41534740-D0B18A3F-4DFA-4AC9-B2B4-ED97DF466974Q42284216-B19F465E-2243-4ADD-A7DA-B16B9B55D96DQ42373192-B3B1935A-9E52-4786-8FD5-2454FD78FDFBQ42380301-459A3504-DEFC-442B-9839-077F3739FB37Q43623208-2BDD7EA7-FE31-447B-9B6F-04211F400B86Q44475261-6DE6041D-D4D0-475E-B4F5-D8D0E77658E8Q45832606-48D611C6-7BEA-4211-AE52-B1E2FBD4DA81Q51035956-FD25E2E8-4D45-4356-B4CA-902C248B236FQ64099682-6D876B12-C70C-4BE6-BAAD-F902F268F584Q64231208-3A1FD7AF-1E39-4FC2-80DA-20A4BFD2693FQ92140002-83543EDA-1BC3-413E-A006-299EE76FE3F0
P50
description
researcher ORCID ID = 0000-0002-5356-0365
@en
wetenschapper
@nl
name
Ting-Yan Shi
@ast
Ting-Yan Shi
@en
Ting-Yan Shi
@es
Ting-Yan Shi
@nl
type
label
Ting-Yan Shi
@ast
Ting-Yan Shi
@en
Ting-Yan Shi
@es
Ting-Yan Shi
@nl
prefLabel
Ting-Yan Shi
@ast
Ting-Yan Shi
@en
Ting-Yan Shi
@es
Ting-Yan Shi
@nl
P106
P31
P496
0000-0002-5356-0365